摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

m-草酰甲苯胺 | 3551-75-5

中文名称
m-草酰甲苯胺
中文别名
——
英文名称
N,N'-bis(3-methylphenyl)oxalamide
英文别名
N,N'-bis(3-methylphenyl)oxamide;N,N'-Bis-(m-tolyl)-oxalsaeurediamid;N,N'-di-m-tolyloxalamide;Oxalsaeure-di-m-toluidid;N,N'-Di-m-tolyl-oxalamid;N.N'-Di-m-tolyl-oxamid;Ethanediamide, N,N'-bis(3-methylphenyl)-
m-草酰甲苯胺化学式
CAS
3551-75-5
化学式
C16H16N2O2
mdl
——
分子量
268.315
InChiKey
SGPZWRDIDBJXET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    135 °C
  • 密度:
    1.241±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2924299090

SDS

SDS:d0075a4d385a155be985eb8bf95b693a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Highly Productive α-Alkylation of Ketones with Alcohols Mediated by an Ir–Oxalamidato/Solid Base Catalyst System
    作者:Hideo Shimizu、Hironori Maeda、Hideki Nara
    DOI:10.1021/acs.oprd.0c00362
    日期:2020.11.20
    An Ir–oxalamidato complex in combination with a solid base (e.g., magnesium aluminometasilicate/Ca(OH)2) significantly improved the catalyst productivity in α-alkylation of methyl ketones with primary alcohols. Optimization through systematic variation of the oxalamidato ligand led to a practical turnover number (TON) of 10 000–40 000.
    Ir-草胺酰胺配合物与固体碱(例如,铝硅酸镁/ Ca(OH)2)结合可显着提高甲基酮与伯醇的α-烷基化反应的催化剂生产率。通过系统改变草酰胺的配体而进行的优化导致实际营业额(TON)为10,000至40,000。
  • Reagent Design and Ligand Evolution for the Development of a Mild Copper-Catalyzed Hydroxylation Reaction
    作者:Patrick S. Fier、Kevin M. Maloney
    DOI:10.1021/acs.orglett.7b01403
    日期:2017.6.2
    modular ligand library, high-throughput experimentation, and rational ligand evolution have led to a novel copper catalyst for the synthesis of phenols with a traceless hydroxide surrogate. The mild reaction conditions reported here enable the late-stage synthesis of numerous complex, druglike phenols.
    模块化配体库的并行合成和质量导向纯化,高通量实验和合理的配体演化,已经导致了一种新型的铜催化剂,可用于合成具有无痕氢氧化物的苯酚。此处报道的温和的反应条件使许多复杂的类药物酚的后期合成成为可能。
  • A Convenient One-Pot Synthesis of Symmetric Secondary and Tertiary Vicinal Diamines
    作者:Charles F. Nutaitis
    DOI:10.1080/00397919208019300
    日期:1992.4
    Abstract A convenient one-pot synthesis of symmetric vicinal diamines utilizing sodium borohydride/trifluoroacetic acid reduction methodology is described .
    摘要 描述了一种利用硼氢化钠/三氟乙酸还原方法方便地一锅法合成对称连二胺的方法。
  • METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL
    申请人:Takasago International Corporation
    公开号:US20210047254A1
    公开(公告)日:2021-02-18
    The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R 1 )(R 2 )Nu (wherein R 1 , R 2 and Nu are as defined below) by reacting an alcohol represented by CH(R 1 )(R 2 )OH (wherein each of R 1 and R 2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by —CHX 1 -EWG 1 or —NR 3 R 4 ; X 1 represents a hydrogen atom or the like; EWG 1 represents an electron-withdrawing group; and each of R 3 and R 4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.
    本发明涉及:将醇的羟基转化为的方法;以及使该方法成为可能的催化剂。根据本发明的将醇的羟基转化为的方法的特征在于,在周期表的7-11族金属群的复合物存在下,通过将一个由CH(R1)(R2)OH(其中R1和R2分别表示氢原子、可选择取代的烷基基团或类似物)表示的醇与一个具有活性质子的化合物(其中Nu表示由—CHX1-EWG1或—NR3R4表示的基团;X1表示氢原子或类似物;EWG1表示电子吸引基团;R3和R4分别表示氢原子、可选择取代的烷基基团或类似物)反应,从而产生一个由CH(R1)(R2)Nu(其中R1、R2和Nu如下定义)表示的化合物。同时,所述反应中至少选择一种来自层状双氢氧化物、复合氧化物和氢氧化钙的固体碱作为催化剂。
  • Synthesis of N,N’-Diarylalkanediamides and Their Antimycobacterial and Antialgal Activity
    作者:Lenka Kubicova、Karel Waisser、Jiri Kunes、Katarina Kralova、Zelmira Odlerova、Milan Slosarek、Jiri Janota、Zbynek Svoboda
    DOI:10.3390/50500714
    日期:——
    A set of N,N'-diarylalkanediamides was synthesized. The compounds were tested for their antimycobacterial and antialgal activity. The antimycobacterial activity of N,N'-diarylalkanediamides depends on the lipophilicity of the respective acid. Antimycobacterially active substances were found only in the series of N,N'-diarylethanediamides and N,N'-diarylbutanediamides. Other compounds (derivatives of pentane-, hexane-, octane- and nonanediamide) were inactive against various strains of mycobacteria. The compounds inhibited growth and chlorophyll production in Chlorella vulgaris. Their relatively low antialgal activity is probably connected with their lowered aqueous solubility, and hence by a restricted passage of the inhibitor through the hydrophilic regions of thylakoid membranes.
    合成了一组N,N'-二芳基烷二胺。对这些化合物进行了抗分枝杆菌和抗藻类活性的测试。N,N'-二芳基烷二胺的抗分枝杆菌活性取决于相应酸的脂溶性。抗分枝杆菌活性物质仅在N,N'-二芳基乙二胺和N,N'-二芳基丁二胺系列中被发现。其他化合物(戊烷、己烷、辛烷和壬烷二胺的衍生物)对各种分枝杆菌株无活性。这些化合物抑制了小球藻(Chlorella vulgaris)的生长和叶绿素的产生。它们相对较低的抗藻类活性可能与其疏水性溶解度降低有关,因此抑制剂通过类囊体膜的亲水区域的通透性受到限制。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物